1.
Impact of Urinary NGAL in Predicting Response of β2 Microglobulin after Bortezomib Base Chemotherapy in Multiple Myeloma Patients. Bangladesh Renal J. 2026;8(1):16-23. doi:10.3329/brej.v8i1.88160